ISDA: 1VJY

Deposition Date 2004-04-07

Release Date 2004-08-31

Last Version Date 2023-12-27

Entry Detail

PDB ID:

1VJY

Keywords:

TRANSFERASE

Title:

Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Spodoptera frugiperda

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.00 Å

R-Value Free:

0.27

R-Value Work:

0.22

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Structures with similar UniProt ID

Protein Blast

Polymer Type:polypeptide(L)
Molecule:TGF-beta receptor type I
Gene (Uniprot):TGFBR1
Chain IDs:A
Chain Length:303
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P36897 Pfam ID:PF00069 EC:2.7.10.2

Ligand Molecules

460

Primary Citation

Identification of 1,5-Naphthyridine Derivatives as a Novel Series of Potent and Selective TGF-beta Type I Receptor Inhibitors.

Gellibert, F, Woolven, J, Fouchet, M.-H, Mathews, N, Goodland, H, Lovegrove, V, Laroze, A, Nguyen, V.-L, Sautet, S, Wang, R, Janson, C, Smith, W, Krysa, G, Boullay, V, De Gouville, A.-C, Huet, S, Hartley, D.Show

J.Med.Chem. 47 4494 4506 (2004)

PMID: 15317461 DOI: 10.1021/jm0400247

Abstact

Optimization of the screening hit 1 led to the identification of novel 1,5-naphthyridine aminothiazole and pyrazole derivatives, which are potent and selective inhibitors of the transforming growth factor-beta type I receptor, ALK5. Compounds 15 and 19, which inhibited ALK5 autophosphorylation with IC50 = 6 and 4 nM, respectively, showed potent activities in both binding and cellular assays and exhibited selectivity over p38 mitogen-activated protein kinase. The X-ray crystal structure of 19 in complex with human ALK5 is described, confirming the binding mode proposed from docking studies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures

Abstact

Feedback Form